Making Impressive Motion: Transition Therapeutics Inc. (NASDAQ:TTHI), Bill Barrett Corp. (NYSE:BBG), Synthetic Biologics Inc. (NYSEMKT:SYN), BioTime (NYSEMKT:BTX)


TeleCommunication Systems Inc. (NASDAQ:TSYS) shares moved up 0.23% in last trading session and ended the day at $4.39. TSYS Gross Margin is 39.10% and its has a return on assets of 1.10%. TeleCommunication Systems Inc. (NASDAQ:TSYS) quarterly performance is 34.66%.

On 13 November, TeleCommunication Systems, Inc. (TCS) (NASDAQ:TSYS), announced that the U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T) will sponsor TCS for the second phase of research, “Constructing Algorithms that Utilize RF Cell Site Propagation Footprints for Wireless Emergency Alerts (WEA).” The research focuses on using area footprints associated with radio frequency (RF) coverage to improve geo-targeting granularity and accuracy for delivery of WEA messages.

Transition Therapeutics Inc. (NASDAQ:TTHI) ended the last trading day at $1.89. Company weekly volatility is calculated as 4.09% and price to cash ratio as 3.11. Transition Therapeutics Inc. (NASDAQ:TTHI) showed a weekly performance of 1.61%.

On 10 November, Transition Therapeutics Inc. (NASDAQ:TTHI) reported a loss of $3.4 million in its fiscal first quarter. On a per-share basis, the Toronto-based company said it had a loss of 9 cents.

On 20 November, Bill Barrett Corp. (NYSE:BBG) shares moved down -6.40% and was closed at $5.85. BBG EPS growth in last 5 year was -22.70%. Bill Barrett Corp. (NYSE:BBG) year to date (YTD) performance is -48.64%.

Bill Barrett (NYSE:BBG) had its target price upped by investment analysts at Barclays from $6.00 to $7.00 in a research report issued on Friday, MarketBeat.com reports. The brokerage currently has an “equal weight” rating on the energy company’s stock. Barclays’ price objective suggests a potential upside of 7.69% from the company’s current price.

Synthetic Biologics Inc. (NYSEMKT:SYN) shares moved up 14.86% in last trading session and ended the day at $2.55. SYN has a return on assets of -180.30%. Synthetic Biologics Inc. (NYSEMKT:SYN) quarterly performance is 17.51%.

Synthetic Biologics, Inc. (NYSE MKT: SYN), announced it is hosting a Microbiome Clinical Program Seminar on Thursday, December 10, 2015 from 9:00 a.m. – 11:30 a.m. EST in New York City.

BioTime, Inc. (NYSEMKT:BTX) caters to the Healthcare space. Its weekly performance is 1.52%. On the last day of trading company shares ended up at $3.33. BioTime, Inc. (NYSEMKT:BTX) distance from 50-day simple moving average (SMA50) is -7.41%.

On 9 November, BioTime, Inc. (NYSEMKT:BTX) reported Total consolidated revenues for the third quarter were $2.3 million, up $1.1 million from $1.2 million for the same period one year ago. Total consolidated revenues for the nine months ended September 30, 2015 were $5.6 million, up $2.2 million from $3.4 million for the same period one year ago. The increase in revenues is primarily attributable to increases in grant income primarily from Israel’s Office of the Chief Scientist and the California Institute for Regenerative Medicine, and from sales of research products and services.


Leave a Reply

Your email address will not be published. Required fields are marked *